Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to vaccine timing in Hajj and Umrah pilgrims
ACTRN12613000536763Phase 2Completed
- Sponsor
- The Children's Hospital at Westmead
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of diphtheria toxoid + tetanus toxoid + acellular pertussis and meningococcal conjugate vaccine, quadrivalent in meningococcal disease, pneumococcal disease, diphtheria and 2 more, sponsored by The Children's Hospital at Westmead. Primary endpoints: Immune response to MCV4, IgG antibodies to diphtheria, pertussis and tetanus and 1 more. Started Jul 2013; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussismeningococcal conjugate vaccine, quadrivalent
03
Conditions
meningococcal diseasepneumococcal diseasediphtheriaTetanuspertussis
Beyond the preview
Go deeper on ACTRN12613000536763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000536763.